
Join to view full profile
200 Medical Plaza, Suite B265Los Angeles, CA 90095
Phone+1 310-825-9771
Fax+1 310-825-9771
Dr. Khan is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
NYU Grossman School of MedicineResidency, Radiation Oncology, 1995 - 1998
NYU Grossman School of MedicineInternship, Internal Medicine, 1994 - 1995
Oregon Health and Science University School of MedicineClass of 1994
Pomona CollegeB.A., Psychooncology, 1985 - 1989
Certifications & Licensure
CA State Medical License 1998 - 2027
NY State Medical License 1996 - 1999
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA Radiation Oncology EMR, Varian Medical Systems, 2014
- Yearlong Post-Sophomore Fellowship in Anatomic Pathology 1991
- Summer Research Fellowship in Otolaryngology 1990
Clinical Trials
Publications & Presentations
PubMed
- 59 citationsReduction in Patient-reported Acute Morbidity in Prostate Cancer Patients Treated With 81-Gy Intensity-modulated Radiotherapy Using Reduced Planning Target Volume Marg...Howard M. Sandler, Ping-Yu Liu, Rodney L. Dunn, David C. Khan, Scott E. Tropper
Urology. 2010-05-01 - 110 citationsLay patient navigator program implementation for equal access to cancer care and clinical trials: essential steps and initial challenges.Michael L. Steinberg, Allen Fremont, David C. Khan, David T. Huang, Herschel Knapp
Cancer. 2006-12-01 - 21 citationsRadiotherapy for the treatment of giant cell tumor of the spine: a report of six cases and review of the literature.David C. Khan, Sujata Malhotra, Randy E. Stevens, Alan D. Steinfeld
Cancer Investigation. 1999-01-01
Journal Articles
- Reduction in Patient-reported Acute Morbidity in Prostate Cancer Patients Treated with 81-Gy Intensity Modulated Radiotherapy Using Reduced Planning Target Volume Marg...Sandler HM, Liu P, Dunn R, Khan DC, Tropper S, Sanda M, Mantz CA, Urology, 1/1/2010
- Preliminary results and evaluation of MammoSite balloon brachtherapy for partial breast irradiation for pure ductal carcinoma in-situ: a phase II clinical studyBenitez PR, Streeter O, Vicini F, Mehta V, Quiet C, Kuske R, Hayes MK, Arthur D, Kuerer H, Freedman G, Keish M, Dipetrillo T, Khan D, Hudes R, Am J Surgery, 1/1/2006
- Targeting For Cure: Intensity Modulated Radiation Therapy Current Status and Future Directions in the Treatment of Prostate CancerLisa M Chaiken, Michael L Steinberg, Afshin Safa, David Khan, Robert Kwon, & Uri Zisblatt, PCRI Insights, 1/1/2004
Abstracts/Posters
- Efficiency and Clinical Workflow of Delivering 81 Gy IMRT to the Prostate Within 2 mm TolerancesTropper S, Khan D, Mantz C, American Society of Radiation Oncology, 1/1/2009
- Development of Otic Capsule Lesions in the Palmerston North Autoimmune Strain MouseKhan DC, Morton JI, Trune DS, Annual Meeting of the American Academy of Otolaryngology, 1/24/1991
Lectures
- Patient-Reduction in Acute GU and GI Side Effects for Prostate Cancer Patients Treated with 81Gy IMRT Using Reduced PTV Margins and Electromagnetic Tracking1/1/2009
- Preliminary results and evaluation of Mammosite balloon Brachytherapy for partial breast irradiation for pure ductal carcinoma in- situ: A phase II clinical study1/1/2006
- Prophylactic Post-Operative Antibiotics for Prostate Brachytherapy: Is it necessary?1/1/2006
Press Mentions
New Radiation Oncology Office Brings Advanced Care to the South BayFebruary 6th, 2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









